Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations

计划入组 84 人 · 首次发布于 2016 年 1 月 21 日

Lundbeck TOMs Orthostatic Hypotension

计划入组 9 人 · 首次发布于 2020 年 8 月 12 日

12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China

计划入组 129 人 · 首次发布于 2008 年 12 月 1 日

MAGLi program (H. Lundbeck)

Citalopram controlled release(H. Lundbeck A/S)

Lu AF-82422(H. Lundbeck A/S)

H. Lundbeck A/S

Denmark

LUNDBECK, LLC

United States

Lundbeck Ltd.

United Kingdom

Vyepti (Eptinezumab) Shows Positive Phase III Results in Asian Migraine Patients

Multiple System Atrophy Pipeline Shows Promise with 22+ Therapies in Development as FDA Grants Fast Track Designations

Longboard Pharmaceuticals Advances Bexicaserin for Dravet Syndrome